These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


393 related items for PubMed ID: 23908345

  • 1. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.
    Ge S, Hertel B, Koltsova EK, Sörensen-Zender I, Kielstein JT, Ley K, Haller H, von Vietinghoff S.
    Circ Res; 2013 Sep 27; 113(8):965-74. PubMed ID: 23908345
    [Abstract] [Full Text] [Related]

  • 2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ, Waseem TC, Galkina EV.
    Arterioscler Thromb Vasc Biol; 2016 Aug 27; 36(8):1496-506. PubMed ID: 27365405
    [Abstract] [Full Text] [Related]

  • 3. Atypical chemokine receptor 1 deficiency reduces atherogenesis in ApoE-knockout mice.
    Wan W, Liu Q, Lionakis MS, Marino AP, Anderson SA, Swamydas M, Murphy PM.
    Cardiovasc Res; 2015 Jun 01; 106(3):478-87. PubMed ID: 25858253
    [Abstract] [Full Text] [Related]

  • 4. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM, Sluimer JC, Koch M, Theelen TL, Manthey HD, Busch M, Caballero-Franco C, Vogel F, Cochain C, Pelisek J, Daemen MJ, Lutz MB, Görlach A, Kissler S, Hermanns HM, Zernecke A.
    Arterioscler Thromb Vasc Biol; 2015 Nov 01; 35(11):2316-25. PubMed ID: 26404487
    [Abstract] [Full Text] [Related]

  • 5. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I, Sluka SH, Rohrer L, Hofmann J, Becher B, Akhmedov A, Soliz J, Mocharla P, Borén J, Johansen P, Steffel J, Watanabe T, Lüscher TF, Tanner FC.
    Arterioscler Thromb Vasc Biol; 2010 May 01; 30(5):923-30. PubMed ID: 20203300
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.
    Koltsova EK, Kim G, Lloyd KM, Saris CJ, von Vietinghoff S, Kronenberg M, Ley K.
    Circ Res; 2012 Oct 26; 111(10):1274-85. PubMed ID: 22927332
    [Abstract] [Full Text] [Related]

  • 7. Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
    Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA, Harrison DG.
    Arterioscler Thromb Vasc Biol; 2011 Jul 26; 31(7):1565-72. PubMed ID: 21474820
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
    Matsumoto T, Sasaki N, Yamashita T, Emoto T, Kasahara K, Mizoguchi T, Hayashi T, Yodoi K, Kitano N, Saito T, Yamaguchi T, Hirata K.
    Arterioscler Thromb Vasc Biol; 2016 Jun 26; 36(6):1141-51. PubMed ID: 27055906
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito K, Kanayama M, Kurotaki D, Morimoto J, Iwakura Y, Yagita H, Tsutsui H, Uede T.
    Arterioscler Thromb Vasc Biol; 2012 Feb 26; 32(2):273-80. PubMed ID: 22116098
    [Abstract] [Full Text] [Related]

  • 10. Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice.
    Shami A, Gustafsson R, Kalamajski S, Krams R, Segers D, Rauch U, Roos G, Nilsson J, Oldberg Å, Hultgårdh-Nilsson A.
    Arterioscler Thromb Vasc Biol; 2013 Feb 26; 33(2):354-61. PubMed ID: 23202368
    [Abstract] [Full Text] [Related]

  • 11. The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.
    Butcher MJ, Gjurich BN, Phillips T, Galkina EV.
    Circ Res; 2012 Mar 02; 110(5):675-87. PubMed ID: 22302786
    [Abstract] [Full Text] [Related]

  • 12. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.
    Xu L, Dai Perrard X, Perrard JL, Yang D, Xiao X, Teng BB, Simon SI, Ballantyne CM, Wu H.
    Arterioscler Thromb Vasc Biol; 2015 Aug 02; 35(8):1787-97. PubMed ID: 26112011
    [Abstract] [Full Text] [Related]

  • 13. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE, Polanowska-Grabowska R, Marqueen K, Griffiths R, Angdisen J, Breevoort SR, Schulman IG, Leitinger N.
    Arterioscler Thromb Vasc Biol; 2018 May 02; 38(5):1020-1029. PubMed ID: 29599136
    [Abstract] [Full Text] [Related]

  • 14. T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.
    Dong L, Nordlohne J, Ge S, Hertel B, Melk A, Rong S, Haller H, von Vietinghoff S.
    J Am Soc Nephrol; 2016 Jun 02; 27(6):1753-64. PubMed ID: 26449606
    [Abstract] [Full Text] [Related]

  • 15. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X, Andonova T, Walker ME, Dalli J, Arnardottir H, Gisterå A, Thul S, Wheelock CE, Paulsson-Berne G, Ketelhuth DFJ, Hansson GK, Bäck M.
    Circulation; 2018 Oct 16; 138(16):1693-1705. PubMed ID: 29739755
    [Abstract] [Full Text] [Related]

  • 16. CD8+ T Cells Drive Plaque Smooth Muscle Cell Dedifferentiation in Experimental Atherosclerosis.
    Schäfer S, Gogiraju R, Rösch M, Kerstan Y, Beck L, Garbisch J, Saliba AE, Gisterå A, Hermanns HM, Boon L, Kastenmüller W, Schäfer K, Cochain C, Zernecke A.
    Arterioscler Thromb Vasc Biol; 2024 Aug 16; 44(8):1852-1872. PubMed ID: 38868941
    [Abstract] [Full Text] [Related]

  • 17. Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr⁻/⁻ mice compared to nondiabetic LDLr⁻/⁻ mice.
    Engelbertsen D, To F, Dunér P, Kotova O, Söderberg I, Alm R, Gomez MF, Nilsson J, Bengtsson E.
    Exp Diabetes Res; 2012 Aug 16; 2012():176162. PubMed ID: 23243415
    [Abstract] [Full Text] [Related]

  • 18. Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation.
    Cremer S, Michalik KM, Fischer A, Pfisterer L, Jaé N, Winter C, Boon RA, Muhly-Reinholz M, John D, Uchida S, Weber C, Poller W, Günther S, Braun T, Li DY, Maegdefessel L, Perisic Matic L, Hedin U, Soehnlein O, Zeiher A, Dimmeler S.
    Circulation; 2019 Mar 05; 139(10):1320-1334. PubMed ID: 30586743
    [Abstract] [Full Text] [Related]

  • 19. Attenuation of experimental atherosclerosis by interleukin-19.
    Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Traylor JG, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV.
    Arterioscler Thromb Vasc Biol; 2013 Oct 05; 33(10):2316-24. PubMed ID: 23950143
    [Abstract] [Full Text] [Related]

  • 20. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis.
    Erbel C, Akhavanpoor M, Okuyucu D, Wangler S, Dietz A, Zhao L, Stellos K, Little KM, Lasitschka F, Doesch A, Hakimi M, Dengler TJ, Giese T, Blessing E, Katus HA, Gleissner CA.
    J Immunol; 2014 Nov 01; 193(9):4344-55. PubMed ID: 25261478
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.